Application for quotation of securities - LME
|
28 June 2023 at 10:35am
|
Preliminary Proxy Statement relating to WebMD Acquisition
|
26 June 2023 at 8:55am
|
Notification of cessation of securities - LME
|
22 June 2023 at 10:10am
|
Ceasing to be a substantial holder
|
16 June 2023 at 12:50pm
|
Final Director's Interest Notice (Lisa MacCallum)
|
15 June 2023 at 5:15pm
|
Results of 2023 AGM
|
15 June 2023 at 2:05pm
|
2023 AGM - Chair Address and CEO Presentation
|
15 June 2023 at 10:10am
|
Change in substantial holding
|
14 June 2023 at 2:50pm
|
Change in substantial holding
|
13 June 2023 at 5:05pm
|
Becoming a substantial holder
|
13 June 2023 at 4:10pm
|
Notice of WebMD Health Services Transaction Announcement
|
9 June 2023 at 8:55am
|
WebMD to Acquire Limeade for A$0.425 per Share/CDI in cash
|
9 June 2023 at 8:55am
|
Notification regarding unquoted securities - LME
|
24 May 2023 at 10:35am
|
Application for quotation of securities - LME
|
24 May 2023 at 10:30am
|
SEC Form 8-K and Form 10-Q (Q1 2023 Results)
|
16 May 2023 at 9:10am
|
Notice of 2023 Annual General Meeting and Proxy Statement
|
5 May 2023 at 6:10pm
|
Application for quotation of securities - LME
|
5 May 2023 at 10:15am
|
Retirement of Board member, Lisa MacCallum
|
1 May 2023 at 9:15am
|
Notification of cessation of securities - LME
|
1 May 2023 at 9:10am
|
Notification regarding unquoted securities - LME
|
1 May 2023 at 9:10am
|
Application for quotation of securities - LME
|
1 May 2023 at 9:05am
|
Potential non-renewal in fiscal 2024 of top-5 customer
|
17 April 2023 at 10:05am
|
Notice of 2023 AGM date and Director nomination closing date
|
6 April 2023 at 9:50am
|
Application for quotation of securities - LME
|
4 April 2023 at 3:40pm
|
Application for quotation of securities - LME
|
28 March 2023 at 2:50pm
|
No exposure to Silicon Valley Bank
|
14 March 2023 at 11:40am
|
FY2022 Appendix 4G
|
1 March 2023 at 10:50am
|
FY2022 Corporate Governance Statement
|
1 March 2023 at 10:40am
|
Investor Presentation on FY2022 Results
|
1 March 2023 at 8:40am
|
ASX Announcement on FY2022 Results
|
1 March 2023 at 8:40am
|
FY2022 SEC Form-10K incorporating Annual Report
|
1 March 2023 at 8:40am
|
Notice of upcoming FY22 results and investor call
|
22 February 2023 at 12:30pm
|
Application for quotation of securities - LME
|
21 February 2023 at 8:55am
|
Change in substantial shareholding from AEF
|
13 February 2023 at 3:59pm
|
Change in substantial holding
|
10 February 2023 at 1:20pm
|
Notification of cessation of securities - LME
|
27 January 2023 at 12:10pm
|
Change in substantial shareholding from AEF
|
25 January 2023 at 11:00am
|
Change in substantial holding
|
24 January 2023 at 12:50pm
|
Application for quotation of securities - LME
|
18 January 2023 at 12:10pm
|
Notification of cessation of securities - LME
|
18 January 2023 at 12:10pm
|
Limeade Announces Restructure for 2023 and CFO Resignation
|
12 January 2023 at 9:20am
|
Limeade signs 3-year US$5.1m contract with Marsh McLennan
|
28 December 2022 at 9:15am
|
Application for quotation of securities - LME
|
15 December 2022 at 11:25am
|
Notification regarding unquoted securities - LME
|
15 December 2022 at 11:25am
|
Limeade Signs Three-Year Contract with Tyson Foods
|
14 December 2022 at 12:05pm
|
Application for quotation of securities - LME
|
12 December 2022 at 9:45am
|
Application for quotation of securities - LME
|
6 December 2022 at 9:20am
|
New three-year customer contract - UPMC Health Plan, Inc.
|
21 November 2022 at 8:50am
|
SEC Form 8-K and Form 10-Q (Q3 2022 Results)
|
15 November 2022 at 9:25am
|
Change to Upcoming Third Quarter Results Reporting Date
|
10 November 2022 at 9:55am
|